Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to OneSource Speci. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
185.90%
EBIT Growth (5y)
67.54%
EBIT to Interest (avg)
0.68
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.24
Sales to Capital Employed (avg)
0.18
Tax Ratio
19.74%
Dividend Payout Ratio
0
Pledged Shares
38.38%
Institutional Holding
38.11%
ROCE (avg)
-5.29%
ROE (avg)
0.80%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
34
Price to Book Value
3.17
EV to EBIT
792.34
EV to EBITDA
65.43
EV to Capital Employed
2.75
EV to Sales
14.00
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.35%
ROE (Latest)
-1.10%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
NET SALES(Q)
Highest at Rs 428.22 cr
-4What is not working for the Company
PAT(Q)
At Rs 4.57 cr has Fallen at -40.6% (vs previous 4Q average
Loading Valuation Snapshot...
Here's what is working for OneSource Speci.
Net Sales - Quarterly
Highest at Rs 428.22 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 428.22 cr has Grown at 20.7% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 354.83 CrMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for OneSource Speci.
Profit After Tax (PAT) - Quarterly
At Rs 4.57 cr has Fallen at -40.6% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 7.69 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
